Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy
<p>Abstract</p> <p>Background</p> <p>To test the hypothesis that point-of-care assays of platelet reactivity would demonstrate reduced response to antiplatelet therapy in patients who experienced Drug Eluting Stent (DES) ST whilst on dual antiplatelet therapy compared t...
Main Authors: | Dawkins Keith D, Morton Geraint, Petley Graham, Hobson Alex R, Curzen Nick P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-02-01
|
Series: | Thrombosis Journal |
Online Access: | http://www.thrombosisjournal.com/content/6/1/1 |
Similar Items
-
Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
by: Pepinghege Fenena, et al.
Published: (2011-01-01) -
SUB-ACUTE STENT THROMBOSIS AND IN-STENT RESTENOSIS ASSOCIATED WITH ANTIPLATELETS CLOPIDOGREL RESISTANCE AND PROTEIN S DEFICIENCY
by: M Zakky Kurniawan, et al.
Published: (2016-11-01) -
Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
by: Hemlata, et al.
Published: (2013-01-01) -
Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV
by: Emanuela Marcantoni, PhD, et al.
Published: (2022-11-01) -
RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)